Antigen-driven affinity maturation of B cells in meningeal ectopic lymphoid tissue in a model of multiple sclerosis

多发性硬化症模型中脑膜异位淋巴组织中抗原驱动的 B 细胞亲和力成熟

基本信息

项目摘要

In secondary progressive multiple sclerosis (SP-MS) and experimental autoimmune encephalomyelitis (EAE), a model of MS, B cell-rich accumulations of lymphoid cells have been identified in the meninges. These aggregates represent meningeal ectopic lymphoid tissue (mELT). Like secondary lymphoid tissue, ectopic lymphoid tissue is thought to contain germinal centers (GC), where B cells proliferate and undergo somatic hypermutation of their immunoglobulin (Ig) genes. This process of antigen-driven affinity maturation may result in B cell receptors and Igs with increased affinity to their target antigens and possibly enhanced pathogenic potential. Although studies, including our own, suggest that mELT contain GCs, their functionality and relevance to disease progression remains poorly characterized. Here, we propose to investigate whether mELT supports antigen-driven affinity maturation and contributes to disease pathogenesis in murine EAE models of central nervous system (CNS) autoimmunity. We will comprehensively characterize the B cell repertoire in mELT, combining laser capture microscopy and next-generation deep immune repertoire sequencing. mELT repertoires will be compared to repertoires in other lymphoid tissues, including CNS-draining cervical lymph nodes. In parallel, a selection of single B cells from mELT will be analyzed. Matching repertoire sequencing data with single cell analyses will provide a novel approach to identifying paired Ig heavy and light chains from overrepresented B cell clones with an a priori estimation of their “evolutionary” standing. Assuming that they are biologically most relevant, these paired Ig sequences will be cloned and express to test their antigen binding affinity as a measure of antigen-driven affinity maturation. Their pathogenic potential will be assessed in vitro and in vivo. This project will contribute to the understanding of the role of B cells and of mELT in CNS autoimmunity and may help identify novel therapeutic targets in treatment of SP-MS.
在继发性进行性多发性硬化症(SP-MS)和实验性自身免疫性脑脊髓炎(EAE)(MS模型)中,已在脑膜中鉴定出富含B细胞的淋巴样细胞积聚。这些聚集体代表脑膜异位淋巴组织(mELT)。像次级淋巴组织一样,异位淋巴组织被认为含有生发中心(GC),其中B细胞增殖并经历其免疫球蛋白(IG)基因的体细胞超突变。这种抗原驱动的亲和力成熟过程可能导致B细胞受体和Ig对其靶抗原的亲和力增加,并可能增强致病潜力。尽管包括我们自己的研究在内的研究表明mELT含有GC,但其功能和与疾病进展的相关性仍然很差。在这里,我们建议研究mELT是否支持抗原驱动的亲和力成熟,并有助于中枢神经系统(CNS)自身免疫的小鼠EAE模型的疾病发病机制。我们将结合激光捕获显微镜和下一代深度免疫库测序,全面表征mELT中的B细胞库。将mELT组库与其他淋巴组织(包括CNS引流颈淋巴结)中的组库进行比较。同时,将分析mELT中选择的单个B细胞。匹配库测序数据与单细胞分析将提供一种新的方法,以确定配对的IG重链和轻链从过度代表的B细胞克隆与先验估计其“进化”的立场。假设它们在生物学上最相关,将克隆并表达这些配对的IG序列以测试它们的抗原结合亲和力,作为抗原驱动的亲和力成熟的量度。将在体外和体内评估其致病潜力。该项目将有助于理解B细胞和mELT在CNS自身免疫中的作用,并可能有助于确定治疗SP-MS的新治疗靶点。

项目成果

期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Intrathecal B-cell activation in LGI1 antibody encephalitis
  • DOI:
    10.1212/nxi.0000000000000669
  • 发表时间:
    2020-03-01
  • 期刊:
  • 影响因子:
    8.8
  • 作者:
    Lehmann-Horn, Klaus;Irani, Sarosh R.;von Budingen, H. -Christian
  • 通讯作者:
    von Budingen, H. -Christian
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Privatdozent Dr. Klaus Lehmann-Horn其他文献

Privatdozent Dr. Klaus Lehmann-Horn的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Privatdozent Dr. Klaus Lehmann-Horn', 18)}}的其他基金

The role of B cells in the inflamed central nervous system: antigen presentation and phenotype-related migration
B 细胞在发炎中枢神经系统中的作用:抗原呈递和表型相关迁移
  • 批准号:
    222193024
  • 财政年份:
    2012
  • 资助金额:
    --
  • 项目类别:
    Research Fellowships

相似国自然基金

Data-driven Recommendation System Construction of an Online Medical Platform Based on the Fusion of Information
  • 批准号:
  • 批准年份:
    2024
  • 资助金额:
    万元
  • 项目类别:
    外国青年学者研究基金项目
基于Cache的远程计时攻击研究
  • 批准号:
    60772082
  • 批准年份:
    2007
  • 资助金额:
    28.0 万元
  • 项目类别:
    面上项目

相似海外基金

Development of edible sorbent therapies to mitigate dietary exposures to per- and polyfluoroalkyl substances (PFAS)
开发可食用吸附剂疗法以减少膳食中全氟烷基物质和多氟烷基物质 (PFAS) 的暴露
  • 批准号:
    10590799
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
TOX-driven CD8 T cell differentiation and dysfunction in tumors
TOX驱动的肿瘤中CD8 T细胞分化和功能障碍
  • 批准号:
    10586679
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Estradiol signaling pathways mediating sex differences in striatal synaptic plasticity
雌二醇信号通路介导纹状体突触可塑性的性别差异
  • 批准号:
    10607187
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Small-molecule exploitation of ZBP1-driven nuclear necroptosis for cancer immunotherapy
ZBP1 驱动的核坏死性凋亡的小分子开发用于癌症免疫治疗
  • 批准号:
    10586659
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Dysregulated mechanoimmunology of epigenetics-driven lymphomas
表观遗传学驱动的淋巴瘤的机械免疫学失调
  • 批准号:
    10669928
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Development and application of a quantitive model for HIV-1 transcriptional activation driven by TAR RNA conformational dynamics
TAR RNA构象动力学驱动的HIV-1转录激活定量模型的开发和应用
  • 批准号:
    10750552
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Pharmacodynamic Biomarker of Myotonic Dystrophy
强直性肌营养不良的药效生物标志物
  • 批准号:
    10651049
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Tiny RNAs as new potential biomarkers for gammaherpesvirus-driven neurological and central nervous system diseases
微小RNA作为伽马疱疹病毒驱动的神经和中枢神经系统疾病的新潜在生物标志物
  • 批准号:
    10727761
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Novel antibody-drug conjugates targeting T-cell lymphoma
靶向 T 细胞淋巴瘤的新型抗体-药物偶联物
  • 批准号:
    10386723
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
Development of Microbial-Based Therapies to Suppress Macropinocytosis in Kras-Driven Cancers
开发基于微生物的疗法来抑制 Kras 驱动的癌症中的巨胞饮作用
  • 批准号:
    10652633
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了